Brazil’s Conselho Federal de Medicina activated Resolution 2.454/2026 on August 26, imposing immediate ethical sanctions on physicians and institutions deploying AI without governance frameworks.
Brazil’s Conselho Federal de Medicina activated Resolution 2.454/2026 on August 26, imposing immediate ethical sanctions on physicians and institutions deploying AI without governance frameworks.
Brazilian startup PoliHealth is integrating genetic, laboratory, and lifestyle data into a single AI platform for clinicians, targeting R$8 million in revenue and 30,000 health professional users within three years.
Anvisa cancelled Elevidys’s conditional registration on August 24 at Roche’s request, citing insufficient safety and efficacy data — ending Brazilian access to the country’s most expensive approved drug.
Anvisa has approved datopotamab deruxtecan (Datroway) for adults with advanced EGFR-mutated non-small cell lung cancer in Brazil, expanding targeted therapy options in one of oncology’s most active segments.
PASSUS IPS, a Colombian healthcare provider, has warned it may suspend services due to unpaid debts from EPS insurers, exposing a structural financing gap in Colombia’s health system.
Brazil’s Ministry of Health and ONA have launched the country’s first accreditation manual for digital health, telemedicine, and telehealth services, establishing a formal quality and safety certification pathway for public …
You must be logged in to post a comment.